Life sciencesOrchestra Bio
A platform for biotech and pharmaceutical teams to coordinate drug-development programs with people and AI agents.
At a glance
- Origins
- 2022-10-20 · founder retrospective
- Category
- Life sciences · drug-development software
Founders in the archive
Origins & connections
Acquired by OpenAI on October 20, 2026. Its team and technology join Rosalind. The founder dated its start to exactly four years before the acquisition announcement.
